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Background To assess the impact of the health care 
reform on stroke prognoses among low-income Chi-
nese residents.
Methods Stroke events and all-cause deaths were reg-
istered during 1992-2018 in Tianjin, China. Trends 
in stroke management and prognoses were compared 
during the study periods1992-2008 and 2009-2018.
Results A total of 1462 patients were diagnosed with 
first-ever stroke during the study periods. For patients 
aged ≥45 years, the rates of neuroimaging-based diag-
noses and hospitalization were greater in 2009-2018 
than in 1992-2008, regardless of patient sex or stroke 
type. Overall, the one-year case fatality rate was sig-
nificantly lower in 2009-2018 than in the earlier peri-
od; the case fatality rate for women aged ≥65 years de-
creased by 30.0%. Between both periods, the stroke 
recurrence rate increased 1.9-fold, including a 2.5-
fold increase in men (all P < 0.05). During the 2009-
2018 period, the one-year case fatality rate was higher 
among elderly male patients not using medical in-
surance than among those using it (32.8% vs 20.7%; 
P = 0.050). After 2009, a significant decline in the re-
currence rate (P = 0.001) and a significant increase in 
the hospitalization rate (P = 0.004) were observed in 
the interrupted time-series analysis.
Conclusions These findings suggest that the imple-
mentation of universal medical insurance for resi-
dents in urban and rural China played a major role 
in improving the prognoses of low-income, rural, 
first-ever stroke patients, especially for elderly (≥65 
years old) residents. However, elderly male patients 
not using medical insurance benefits had a high 
case fatality rate. Thus, restructuring of the govern-
ment medical insurance policy to facilitate its use by 
low-income, rural residents is crucial for reducing the 
stroke burden in China.
Cite as: Liu J, Lin Q, Gao Y, Zhang Y, Qi D, Wang C, Tu J Wang Y, Ning X, Wang J. 
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Government underfunding and a dearth of health insurance coverage induced widespread public discontent 
with the limited access and prohibitive costs associated with China’s health care system. In April 2009, Chi-
na unveiled a huge and complex health reform plan that pledged to provide all citizens, by 2020, with equal 
access to reasonable-quality, basic health care services and with financial risk protection [1]. Over the past 
decade, China has made substantial progress towards this goal, especially for people of a lower socioeconom-
ic status [2]. Over this period, government health care expenditures rose from CN¥359 billion (5.7% of total 
government spending) in 2008 to CN¥1.52 trillion (7.5% of total government spending) in 2017, comprising 
1.1% and 1.8% of the gross domestic product, respectively [3]. Moreover, by 2013, insurance coverage was 
provided to >95% of the country’s population [4]. However, some gaps remain, including control of non-com-
municable diseases.
Stroke remains the second leading cause of death worldwide [5] and is the leading cause of death and dis-
ability adjusted life years (DALYs) in China [6]. However, the age-standardized DALYs for stroke decreased by 
33.1% per 100 000 population during the 1990-2017 period. Although stroke incidence and mortality have 
remained relatively stable, in China, their prevalences continue to increase [7]. With more than 2 million new 
strokes occurring each year, this disease accounts for the highest number of DALYs among all diseases, in Chi-
na [6]. Nevertheless, according to the national Healthcare Access and Quality Access index, stroke placed sec-
ond lowest among 32 diseases or conditions from which death is preventable. This ranking indicated there 
were inadequate social and medical investments in stroke care, compared with other diseases [8]. These key 
findings demonstrated that the various strategies for the prevention and control of this disease have not been 
effectively implemented, in China [7].
The availability of stroke care varies across the country and is especially uneven in rural areas, despite improve-
ments in overall health services [7]. Although standardized secondary prevention can effectively reduce stroke 
mortality and recurrence, medicines for the secondary prevention of strokes are unavailable and unafford-
able for low-income residents. This results in a very low proportion of these individuals using such medicines 
[9,10]. Our previous study reported that the overall incidence of first-ever strokes in rural China increased 
by 6.5%, annually, between 1992 and 2012 [11], with the stroke burden focused on young and middle-aged 
adults [12]. However, data regarding the effectiveness of the national health care reforms at improving stroke 
prognoses are scarce, especially among low-income populations. Thus, we aimed to assess the effectiveness 
of 10 years of health care reform on improving stroke prognoses in a low-income population, in China, be-
tween 1992 and 2018.
METHODS
Study population
The study participants were originally recruited, beginning in 1985, for the Tianjin Brain Study, which was 
a population-based, stoke surveillance study in a township in Tianjin, China. All patients who experienced 
first-ever strokes between 1992 and 2018 were included in this population-based prospective study. The year 
1992 was chosen as the starting year because neuroimaging procedures (such as computerized tomography) 
were not available in Tianjin before that year.
The demographic characteristics of the study population were previously described [11,13,14]. Briefly, the 
study enrolled the residents of 18 administrative villages, 95% of whom were farmers with relatively low levels 
of income and education. The main source of income was grain production, and the residents had an annu-
al per capita income of<$100 in 1991 and<$1000 in 2010 [4]. In 1991, the illiteracy rate of this population, 
aged 35-74 years, was 30% for men and 40% for women [15]. Few of these residents were covered by the na-
tional medical insurance before 2009.
This study was approved by the ethics committee of Tianjin Medical University General Hospital; written in-
formed consent was obtained from each participant during recruitment.
Medical insurance information
In China, there are two types of medical insurance: the formal sector employee medical insurance scheme and 
the resident medical insurance scheme. Tianjin’s urban and rural residents’ medical insurance reached univer-
sal coverage after the 2009 health care reform [1,16]; before that, medical insurance was scarce in rural areas.
The medical insurance threshold fee is defined as the boundary value for reimbursement of minimum med-
ical expenses. Residents can receive reimbursement for hospitalization expenses and outpatient (emergency) 
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expenses, after deducting the threshold fee. Inpatient expenses are reimbursed at 60%-80% and outpatient 
(emergency) medical expenses are reimbursed at 50% [17]. In the present study, we used 2008 (immediately 
before the health care reform) as the time boundary for comparing the prognoses of first-ever stroke patients 
before and after health care reform.
Definitions
Stroke management was categorized using the rates of neuroimaging-based diagnoses and hospitalization. Neu-
roimaging-based diagnosis was defined as patients whose first-ever strokes were diagnosed using computed 
tomography or magnetic resonance imaging. The rate of neuroimaging-based diagnoses was calculated using 
the number of patients whose strokes were diagnosed by neuroimaging divided by the number of all first-ev-
er stroke patients. Hospitalization was defined as admission to a county central hospital or to a tertiary-care 
hospital, and the hospitalization rate was calculated using the number of hospitalized stroke patients divided 
by the number of all first-ever stroke patients. On the other hand, stroke prognosis was categorized using the 
case fatality and recurrence rates. A case fatality was defined as death within one year of a first-ever stroke on-
set; the rate was calculated by dividing the number of stroke patients who died within 30 days of stroke onset 
by the number of all first-ever stroke patients. Recurrence was defined as a new stroke event occurring >30 
days after a first-ever stroke; the rate was calculated by dividing the number of recurrent stroke patients by the 
number of all first-ever stroke patients.
A first-ever stroke was defined as the first occurrence (no prior history of stroke in patient medical records) of 
rapidly developing signs of focal neurological disturbances of presumed vascular etiology lasting >24 hours 
[17]. Stroke events included ischemic stroke (IS), hemorrhagic stroke, and undetermined stroke in this study. 
IS was defined as a thrombotic brain infarction, cardioembolic stroke, or lacunar infarct; hemorrhagic stroke 
was defined as intracerebral hemorrhage or subarachnoid hemorrhage; undetermined strokes were defined as 
strokes that could not be classified into the previously defined types.
All stroke events were full clinical strokes, diagnosed according to pre-established criteria for clinical features 
and imaging evidence. This definition excluded transient ischemic attacks and silent strokes (those diagnosed 
using imaging only), but stroke patients with histories of transient ischemic attacks were regarded as suffer-
ing incident events. All patients diagnosed using neuroimaging underwent either computed tomography or 
magnetic resonance imaging at the county central or tertiary care hospital within 24 hours of stroke onset.
Stroke surveillance and quality control
A stroke surveillance network was established in 1985 [13]; briefly, stroke events were confirmed using the fol-
lowing procedures. First, locally licensed village doctors reported the events to the community hospital within 
24 hours of onset (main source of incidence monitoring). Second, for outpatients, community hospital phy-
sicians visited the patients’ homes to confirm the events within 72 hours of onset; for inpatients, physicians 
acquired the patients’ medical records after they were discharged from the hospitals. Confirmed events were 
reported monthly to neurologists at Tianjin Medical University. Finally, neurologists confirmed all reported 
events through a door-to-door survey. Another source of incident stroke data was the all-cause death regis-
try, which supplemented missing stroke events. During follow-up, local doctors reported patient outcomes 
within the first year of a first-ever stroke. The screening of stroke patients in this study covered all permanent 
residents in Tianjin.
The senior neurologists at Tianjin Medical University General Hospital trained the local area doctors, annually, 
to ensure accurate reporting of stroke events. The Quality Control Group conducted annual omission surveys 
that involved comparing multiple overlapping sources, including hospital admission registers, local death reg-
isters, and interviews with the relatives of patients, to reduce the number of missing events.
Patient data, including name, sex, age, and years of formal education, were collected through face-to face in-
terviews with patients or their relatives and were conducted by well-trained epidemiology professionals.
Statistical analysis
Because the rural medical insurance scheme has only been in place since 2009, first-ever strokes and their out-
comes were analyzed over two separate periods, 1992-2008 and 2009-2018. The data were analyzed for both 
men and women after classifying the patients into three age groups (<45, 45-64, ≥65 years). Continuous variables 
are expressed as means (standard deviations), and categorical variables are expressed as numbers (frequencies). 
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the χ2 test for dichotomous variables. Statistical significance was defined at P < 0.05. The interrupted time-series 
analysis was performed to assess the impact of health reform on the management and prognosis of stroke. The 
period 1992-2008 was defined as the period before health reform, and 2009-2018 was defined as the period af-
ter health reform. The slope of the trend was presented as the impact of health reform on the management and 
prognosis of stroke. SPSS for Windows® (version 19.0, SPSS, Chicago, IL, USA) was used to conduct the analyses.
RESULTS
A total of 1462 patients (58.7% males) experi-
enced first-ever strokes between January 1, 1992, 
and December 31, 2018. In these patients, the 
mean age of onset was 66.85 years, and53.2% of 
patients were ≥65 years old. A larger percentage of 
patients were aged 45-64 years during the 2009-
2018 (47.7%) period than during the earlier pe-
riod (35.9%; P < 0.001). ISs accounted for 77.6% 
of the overall stroke events, with a significant in-
crease in the proportion of IS events between the 
later (81.2%) and earlier (73.4%, P < 0.001) peri-
ods (Table 1).
Table 2 shows that there were increases in the pro-
portions of patients diagnosed using neuroimag-
ing and who were hospitalized during the 2009-
2018 period than during the earlier period, for all strokes (P < 0.001), with similar trends observed for both 
men and women. The rate of neuroimaging-based diagnoses, however, remained relatively constant for pa-
tients with hemorrhagic strokes (P > 0.05).
Table 1. Demographical characteristics of all patients by study periods
Category 1992-2018 1992-2008 2009-2018 P-value
Case, n (%) 1462 (100.0) 668 (45.7) 794 (54.3)
Gender, n (%): 0.524
Men 858 (58.7) 398 (59.6) 460 (57.9)
Women 604 (41.3) 270 (40.4) 334 (42.1)
Age, years, means (SD) 66.85 (11.89) 66.48 (11.70) 65.31 (12.03) 0.62
Age group (years), n (%): <0.001
<45 65 (4.4) 30 (4.5) 35 (4.4)
45-64 619 (42.3) 240 (35.9) 379 (47.7)
≥65 778 (53.2) 398 (59.6) 380 (47.9)
Education, years, means (SD) 3.50 (3.46) 2.19 (2.99) 4.59 (3.46) <0.001
Stroke subtypes, n (%): <0.001
Ischemic stroke 1135 (77.6) 490 (73.4) 645 (81.2)
Hemorrhagic stroke 271 (18.5) 136 (20.4) 135 (17.0)
Unknown 56 (3.8) 42 (6.3) 14 (1.8)
SD – standard deviation
Table 2. Management of first-ever stroke by gender and stroke types during 1992 to 2018
Items
Total Men Women
1992-2018 1992-2008 2009-2018 1992-2018 1992-2008 2009-2018 1992-2018 1992-2008 2009-2018
Stroke, n (%):
Diagnosis use CT/MRI 1149 (78.6) 442 (66.2) 707 (89.0)* 672 (78.3) 268 (67.3) 404 (87.8)* 477 (79.0) 174 (64.4) 303 (90.7)*
Hospitalized 483 (33.0) 84 (12.6) 399 (50.3)* 280 (32.6) 47 (11.8) 233 (50.7)* 203 (33.6) 37 (13.7) 166 (49.7)*
Ischamic stroke, n (%):
Diagnosis use CT/MRI 896 (78.9) 320 (65.3) 576 (89.3)* 519 (78.2) 195 (66.3) 324 (87.6)* 377 (80.0) 125 (63.8) 252 (91.6)*
Hospitalized 368 (32.4) 54 (11.0) 314 (48.7)* 213 (32.1) 32 (10.9) 181 (48.9)* 155 (32.9) 22 (11.2) 133 (48.4)*
Hemorrhagic stroke, n (%):
Diagnosis use CT/MRI 253 (93.4) 122 (89.7) 131 (97.0)* 153 (95.0) 73 (92.4) 80 (97.6) 100 (90.9) 49 (86.0) 51 (96.2)
Hospitalized 115 (42.4) 30 (22.1) 85 (63.0)* 67 (41.6) 15 (19.0) 52 (63.4)* 48 (43.6) 15 (26.3) 33 (62.3)*
*Indicates P < 0.05 compared between 1992-2008 and 2009-2018.
Moreover, among patients <45 years old, the hospitalization rates were higher for men and the total patient 
population for all strokes during the 2009-2018 period than during the 1992-2008; women did not show a 
similar trend. For patients ≥45 years old, the hospitalization rate during the 2009-2018 period was higher than 
during the 1992-2008 period, regardless of sex or stroke type. The percentage of patients (≥45 years old) di-
agnosed with ISs (and total strokes), using neuroimaging, was significantly higher during the 1992-2008 pe-
riod than during the later period (Table 3).
For all patients, the one-year case fatality rate for first-ever strokes in 2009-2018 decreased by 27.8%, overall, 
compared with 1992-2008 (P = 0.002). This included a 23.4% decrease among men (P = 0.043) and a 34.2% 
decrease among women (P = 0.012). However, the recurrence rate among men was 1.3-fold higher during the 
2009-2018 period, compared with the 1992-2008 period (P = 0.006). There were no significant changes in 
the one-year outcomes, across stroke types, between the study periods (Table 4).
Table 5 indicates the absence of significant changes in case fatality or recurrence rates, between the two pe-
riods, for patients aged <65 years, regardless of stroke type. However, the overall one-year case fatality rate 
for all stroke patients aged ≥65 years during the 2009-2018 period was lower than that during the 1992-
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Table 3. Management of first-ever stroke by age, gender, and stroke types during 1992 to 2018
Items
<45 years 45-64 years ≥65 years
1992-2008 2009-2018 P-value 1992-2008 2009-2018 P-value 1992-2008 2009-2018 P-value
Stroke
Men:
Diagnosis use CT/MRI 12 (85.7) 18 (100.0) 0.098 118 (84.9) 231 (98.7) <0.001 138 (56.3) 155 (74.5) <0.001
Hospitalized 1 (7.1) 13 (72.2) <0.001 32 (23.0) 132 (56.4) <0.001 14 (5.7) 88 (42.3) <0.001
Women:
Diagnosis use CT/MRI 15 (93.8) 17 (100.0) 0.295 88 (87.1) 142 (97.9) 0.001 71 (46.4) 144 (83.7) <0.001
Hospitalized 6 (37.5) 7 (41.2) 0.829 20 (19.8) 84 (57.9) <0.001 11 (7.2) 75 (43.6) <0.001
Total:
Diagnosis use CT/MRI 27 (90.0) 35 (100.0) 0.055 206 (85.8) 373 (98.4) <0.001 209 (52.5) 299 (78.7) <0.001
Hospitalized 7 (23.3) 20 (57.1) 0.006 52 (21.7) 216 (57.0) <0.001 25 (6.3) 163 (42.9) <0.001
Ischamic stroke
Men:
Diagnosis use CT/MRI 9 (90.0) 8 (100.0) 0.357 87 (82.1) 181 (98.9) <0.001 99 (55.6) 135 (75.4) <0.001
Hospitalized 1 (10.0) 4 (50.0) 0.060 22 (20.8) 103 (56.3) <0.001 9 (5.1) 74 (41.3) <0.001
Women:
Diagnosis use CT/MRI 10 (90.9) 9 (100.0) 0.353 62 (88.6) 117 (97.5) 0.011 53 (46.1) 126 (86.3) <0.001
Hospitalized 4 (36.4) 4 (44.4) 0.714 11 (15.7) 66 (55.0) <0.001 7 (6.1) 63 (43.2) <0.001
Total:
Diagnosis use CT/MRI 19 (90.5) 17 (100.0) 0.191 149 (84.7) 298 (98.3) <0.001 152 (51.9) 261 (80.3) <0.001
Hospitalized 5 (23.8) 8 (47.1) 0.133 33 (18.8) 169 (55.8) <0.001 16 (5.5) 137 (42.2) <0.001
Hemorrhagic stroke
Men:
Diagnosis use CT/MRI 3 (100.0) 10 (100.0) - 31 (100.0) 50 (98.0) 0.433 39 (86.7) 20 (95.2) 0.292
Hospitalized 0 (0.0) 9 (90.0) 0.003 10 (32.3) 29 (56.9) 0.031 5 (11.1) 14 (66.7) <0.001
Women:
Diagnosis use CT/MRI 5 (100.0) 8 (100.0) - 26 (89.7) 25 (100.0) 0.098 18 (78.3) 18 (90.0) 0.298
Hospitalized 2 (40.0) 3 (37.5) 0.928 9 (31.0) 18 (72.0) 0.003 4 (17.4) 12 (80.0) 0.004
Total:
Diagnosis use CT/MRI 8 (100.0) 18 (100.0) - 57 (95.0) 75 (98.7) 0.207 57 (83.8) 38 (92.7) 0.181
Hospitalized 2 (25.0) 12 (66.7) 0.049 19 (31.7) 47 (61.8) <0.001 9 (13.2) 26 (63.4) <0.001
Table 4. Outcomes within one year after first-ever stroke by gender, and stroke types during 1992 to 2018
Outcomes Total 1992-2008 2009-2018 P-value
Stroke
Case fatality:
Men 183 (21.3) 97 (24.4) 86 (18.7) 0.043
Women 116 (19.2) 64 (23.7) 52 (15.6) 0.012
Total 299 (20.5) 161 (24.1) 138 (17.4) 0.002
Recurrence:
Men 48 (5.6) 13 (3.3) 35 (7.6) 0.006
Women 24 (4.0) 7 (2.6) 17 (5.1) 0.118
Total 72 (4.9) 20 (3.0) 52 (6.5) 0.002
Ischemic stroke
Case fatality:
Men 86 (13.0) 36 (12.2) 50 (13.5) 0.629
Women 42 (8.9) 19 (9.7) 23 (8.4) 0.618
Total 128 (11.3) 55 (11.2) 73 (11.3) 0.961
Recurrence:
Men 42 (6.3) 11 (3.7) 31 (8.4) 0.015
Women 19 (4.0) 5 (2.6) 14 (5.1) 0.167
Total 61 (5.4) 16 (3.3) 45 (7.0) 0.006
Outcomes Total 1992-2008 2009-2018 P-value
Hemorrhagic stroke
Case fatality:
Men 66 (41.0) 37 (46.8) 29 (35.4) 0.139
Women 51 (46.4) 28 (49.1) 23 (43.4) 0.547
Total 117 (43.2) 65 (47.8) 52 (38.5) 0.123
Recurrence:
Men 6 (3.7) 2 (2.5) 4 (4.9) 0.432
Women 5 (4.5) 2 (3.5) 3 (5.7) 0.588
Total 11 (4.1) 4 (2.9) 7 (5.2) 0.349
Undetermined strokes
Case fatality:
Men 31 (93.9) 24 (96.0) 7 (87.5) 0.380
Women 23 (100) 17 (100) 6 (100) -
Total 54 (96.4) 41 (97.6) 13 (92.9) 0.406
Recurrence:
Men – – – –
Women – – – –
Total – – – –
2008 period (25.5% vs 33.7%; P = 0.013); the case fatality rate for women ≥65 years old decreased by 30.0% 
(23.3% vs 33.3%; P = 0.043). Between the two study periods, the overall stroke recurrence rate increased 1.9-
fold (P = 0.001), and the recurrence rate among male patients aged ≥65 years increased 2.5-fold (P = 0.010). 
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including by 30.0% among men (P = 0.043), between both study periods; the recurrence rate increased sig-
nificantly among men (P = 0.036). Meanwhile, there were no significant changes in the one-year outcomes in 
undetermined strokes between both study periods (all P > 0.05).
Since 2009, more than 95% of the residents in the study population were covered by universal medical insur-
ance. However, only 52% of the stroke patients used their medical insurance; the remaining 48% did not as 
they could not afford the threshold fee. During the 2009-2018 period, the overall one-year case fatality rate 
for first-ever strokes was higher among male patients who did not use medical insurance (22.6%) than among 
those who did (15.2%; P = 0.043). A similar trend was observed among patients aged ≥65 years; the case fatal-
ity rate was 20.7% for the insured patients and 32.8% for the un-insured patients (P = 0.050). However, there 
were no significant differences in the recurrence rates, regardless of age (Table 6).
The interrupted time-series analysis showed that before the implementation of the policy (1992-2008), the case 
fatality rate decreased, and the slope was -0.012 (95% CI = -0.022, -0.003; P = 0.015). After the implementation 
of the policy (2009-2018), the slope of the case fatality rate was -0.008 (95% CI = -0.031, -0.015; P = 0.443). 
In 1992-2008, the recurrence rate increased, with a slope of 0.004 (95% CI = 0.002, 0.006; P < 0.001), while 
in 2009-2018, the recurrence rate decreased, with a slope of-0.005 (95% CI = -0.011, 0.000; P = 0.061). In 
addition, for hospitalization, the corresponding slopes for both periods were 0.011 (95% CI = 0.007, 0.015; 
P < 0.001) and 0.044 (95% CI = 0.010, 0.077; P = 0.017), and for diagnosis using neuroimaging, the correspond-
ing slopes for both periods were 0.031 (95% CI = 0.018, 0.045; P < 0.001) and 0.017 (95% CI = 0.002, 0.031; 
Table 5. Outcomes within one year after first-ever stroke by age, gender, and stroke types during 1992 to 2018
Outcomes
<45 years 45-64 years ≥65 years
1992-2008 2009-2018 P-value 1992-2008 2009-2018 P-value 1992-2008 2009-2018 P-value
Stroke
Case fatality:
Man 1 (7.1) 3 (16.7) 0.419 13 (9.4) 26 (11.1) 0.591 83 (33.9) 57 (27.4) 0.137
Woman 2 (12.5) 2 (11.8) 0.948 11 (10.9) 10 (6.9) 0.270 51 (33.3) 40 (23.3) 0.043
Total 3 (10.0) 5 (14.3) 0.600 24 (10.0) 36 (9.5) 0.837 134 (33.7) 97 (25.5) 0.013
Recurrence:
Man 0 0 – 6 (4.3) 14 (6.0) 0.490 7 (2.9) 21 (10.1) 0.010
Woman 0 0 – 3 (3.0) 7 (4.8) 0.468 4 (2.6) 10 (5.8) 0.156
Total 0 0 – 9 (3.8) 21 (5.5) 0.312 11 (2.8) 31 (8.2) 0.001
Ischemic stroke
Case fatality:
Man 0 0 – 1 (0.9) 7 (3.8) 0.150 35 (19.7) 43 (24.0) 0.319
Woman 0 0 – 1 (1.4) 1 (0.8) 0.698 18 (15.7) 22 (15.1) 0.897
Total 0 0 – 2 (1.1) 8 (2.6) 0.267 53 (18.1) 65 (20.0) 0.546
Recurrence:
Man 0 0 – 4 (3.8) 12 (6.6) 0.319 7 (3.9) 19 (10.6) 0.015
Woman 0 0 – 2 (2.9) 5 (4.2) 0.644 3 (2.6) 9 (6.2) 0.173
Total 0 0 – 6 (3.4) 17 (5.6) 0.277 10 (3.4) 28 (8.6) 0.007
Hemorrhagic stroke
Case fatality:
Man 0 (0.0) 3 (30.0) 0.279 10 (32.3) 19 (37.3) 0.646 27 (60.0) 7 (33.3) 0.043
Woman 2 (40.0) 2 (25.0) 0.569 8 (27.6) 9 (36.0) 0.507 18 (78.3) 12 (60.0) 0.193
Total 2 (25.0) 5 (27.8) 0.883 18 (30.0) 28 (36.8) 0.402 45 (66.2) 19 (46.3) 0.042
Recurrence:
Man 0 0 – 2 (6.5) 2 (3.9) 0.606 0 (0.0) 2 (9.5) 0.036
Woman 0 0 – 28 (96.6) 23 (92.0) 0.467 1 (4.3) 1 (5.0) 0.919
Total 0 0 – 3 (5.0) 4 (5.3) 0.945 1 (1.5) 3 (7.3) 0.116
Undetermined strokes
Case fatality:
Man 1 (100) 0 – 2 (100) 0 – 21 (95.5) 7 (87.5) 0.440
Woman - 0 – 2 (100) 0 – 15 (100) 6 (100) –
Total 1 (100) 0 – 4 (100) 0 – 36 (97.3) 13 (92.9) 0.466
Recurrence:
Man 0 0 – 0 0 – 0 0 –
Woman 0 0 – 0 0 – 0 0 –
Total 0 0 – 0 0 – 0 0 –
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P = 0.027). After 2009, a significant decline in the recurrence 
rate (P = 0.001) and a significant increase in the hospitaliza-
tion rate (P = 0.004) occurred. However, no significant differ-
ences were observed for trends incase fatality (P = 0.702) and 
diagnosis using neuroimaging (P = 0.285; Figure 1).
DISCUSSION
This is the first report describing the association of stroke 
outcomes with the utilization of medical insurance in a 
low-income population in rural China following the 2009 
national health care reform. The preponderant stroke type 
was IS, the proportion of which increased significantly from 
the pre-reform (1992-2008) to the post-reform (2009-2018) 
period. The proportions of strokes diagnosed using neu-
roimaging and patients who were hospitalization also sig-
nificantly increased between the later and earlier periods, 
especially among patients aged ≥45 years. The increase in 
hospitalization rate was significantly higher in 2009-2018 
than in 1992-2008. For all first-ever stroke patients, the one-
year case fatality rate during the 2009-2018 period was lower for both males and females than it was during 
the earlier period. The trend of overall recurrence rate decreased after 2009, although the recurrence rate in 
men was 1.3-fold higher in 1992-2008 than in 2009-2018. Moreover, the overall one-year case fatality rate 
for patients aged ≥65 years was lower during the later period than during the earlier one; the recurrence rates 
for all strokes, ISs, and hemorrhagic strokes were higher among men. During the 2009-2018 period, the over-
all (and male) case fatality rate was higher among non-insured patients than among insured patients; among 
patients aged ≥65 years, there were 58.5% more case fatalities among the non-insured patients than among 
the insured patients.
A population-based survey of 480 687 adults, in China, indicated that the stroke incidence has declined in ur-
ban areas and risen in rural areas over the past 30 years [18]. Our previous study demonstrated that, in rural 
China, the IS incidence increased sharply, particularly among middle aged adults, between 1992 and 2012 
[19]. However, prior to 2008, the percentage of rural stroke patients undergoing computed tomography ex-
aminations was low [20], reflecting the low level of medical spending in rural areas before 2009. However, 
Table 6. Outcomes within one year after first-ever stroke by application of medical insurance during 2009 to 2018




Case number 794 (100) 413 (52.0) 381 (48.0) –
Case fatality:
Men 86 (18.7) 37 (15.2) 49 (22.6) 0.043
Women 52 (15.6) 25 (14.8) 27 (16.4) 0.692
Total 138 (17.4) 62 (15.0) 76 (19.9) 0.072
Recurrence:
Men 35 (7.6) 18 (7.4) 17 (7.8) 0.863
Women 17 (5.1) 10 (5.9) 7 (4.2) 0.486




Men 3 (16.7) 3 (23.1) 0 0.522
Women 2 (11.8) 1 (50.0) 1 (50.0) 1.000
Total 5 (14.3) 4 (19.0) 1 (7.1) 0.627
Recurrence:
Men 0 0 0 –
Women 0 0 0 –
Total 0 0 0 –






Men 26 (11.1) 15 (10.9) 11 (11.5) 0.888
Women 10 (6.9) 7 (8.3) 3 (4.9) 0.520
Total 36 (9.5) 22 (9.9) 14 (8.9) 0.745
Recurrence:
Men 14 (6.0) 10 (7.2) 4 (4.2) 0.329
Women 7 (4.8) 3 (3.6) 4 (6.6) 0.454




Men 57 (27.4) 19 (20.7) 38 (32.8) 0.050
Women 40 (23.3) 17 (22.1) 23 (24.2) 0.742
Total 97 (25.5) 36 (21.3) 61 (28.9) 0.091
Recurrence:
Men 21 (10.1) 8 (8.7) 13 (11.2) 0.550
Women 10 (5.8) 7 (9.1) 3 (3.2) 0.114
Total 31 (8.2) 15 (8.9) 16 (7.6) 0.647
Figure 1. The interrupted time-series analysis of management and prog-
nosis among stroke patients. Figure 1 showed that a significant decline 
in the recurrence rate (P = 0.001) and a significant increase in the hos-
pitalization rate (P = 0.004) occurred after 2009. However, no signifi-
cant differences were observed for trends incase fatality (P = 0.702) and 
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according to 2019 data from the National Bureau of Statistics of China [21], bed utilization rates in township 
health centers have increased from 55.8% (2008) to 59.6% (2018) and the personally financed proportion 
of medical expenses has increased from 7.8% to 10.2%. A study from Gansu, China indicated that both total 
and out-of-pocket costs have fallen, while actual compensation rates have risen since the implementation of 
the new rural health insurance payment system [22]. Before 2008, 79% of rural residents and 45% of urban 
residents did not have health insurance; in 2018, health care insurance covered >95% of China’s citizens [3]. 
Between 2008 and 2017, outpatient visits increased by 12.1% at tertiary hospitals, by 3.4% at secondary lev-
el hospitals, and by 4.4% at primary health care facilities, annually; per outpatient visit charges increased at 
6.7%-7.1%, annually [2]. In this study, the proportions of patients diagnosed using neuroimaging and who 
were hospitalized, were significantly higher during the 2009-2018 period than during the 1992-2008 peri-
od, especially among patients ≥45 years old. These findings demonstrated that the health care system has im-
proved the ability of rural residents to pay for medical care; this is especially apparent among middle-aged and 
elderly patients. Although China’s health care reform began only 13 years ago, its achievements are obvious.
The one-year case fatality rate for first-ever stroke patients during the 2009-2018 period was significantly 
lower than during the 1992-2008 period, especially among female patients aged ≥65 years. In China, health 
care for women, especially elderly women, was neglected due to their low socioeconomic status. Thus, elder-
ly women were often treated at home or by the local village doctor. The results of this study demonstrate, to a 
certain extent, that the universal medical insurance, implemented in 2009, has benefited rural residents and 
decreased the stroke burden.
For most post-stroke patients, secondary prevention medications are now prescribed, beginning during hospi-
talization; however, poor post-discharge adherence continues to be a problem, especially in rural China [18,19]. 
A previous study reported that among post-stroke patients, only 10.6%, 10.1%, 7.6%, 2.3%, 18.2%, and 1.4% 
were regularly taking antiplatelet drugs, β-blockers, angiotensin-converting enzyme inhibitors, diuretics, calci-
um-channel blockers, and statins, respectively [19]. In one study [18], the use of anti-platelet agents (18.6%) 
and any of the blood pressure (BP)-lowering drugs (38.2%) by patients with histories of either ischemic heart 
disease or stroke, in China, were much lower than for patients in similar North American [20] (anti-platelet 
drugs, 52.2%; BP-lowering medication, 69.2%) and Middle Eastern (anti-platelet drugs, 49.7%; BP-lowering 
medication, 64.3%) studies. In addition, there were significantly different levels of secondary prevention pro-
vided to patients with high socioeconomic status than to those with low socioeconomic status, in China [18]. 
Part of the reason for the alarmingly low use of secondary prevention medications is the inadequate ability of 
low-income people to pay for these medications [18,21]. In the present study, although the one-year stroke 
case fatality rate was remarkably lower during the 2009-2018 period than during the 1992-2008 period, the 
stroke recurrence rate during the later period was more than twice that during the earlier period, indicating 
that the secondary prevention of cerebrovascular disease is far from ideal in rural China. Both the poor aware-
ness of the benefits of secondary prevention methods and the inability to pay for medicines, among rural res-
idents, are major causes of the high recurrence rate [22]. However, the downward trend in the recurrence 
rate of stroke showed that the universal medical insurance in China plays a positive role in stroke recurrence.
Although the Chinese government has implemented a universal medical insurance policy [2], there are still 
some low-income groups who are unable to pay even the threshold fee. Moreover, stroke recurrence aggra-
vates poverty, forming a vicious circle in low-income populations. As a result, China will continue to expe-
rience an enormous health burden due to strokes as >41.48% of the total population lives in rural areas [3].
Many of the health inequities in low- and middle-income countries are related to insurance status. Thus, the 
inevitable consequence is that serious and costly diseases, like strokes, very often have disastrous financial con-
sequences for the patients and their families, especially for low-income patients in rural areas. Out-of-pocket 
payments, as a portion of total health care spending, are very high in both China and India [23,24]. Accord-
ing to a 2003 national census, 45% of residents in urban areas and 80% of those in rural areas of China were 
not covered by public insurance [25]. In April 2009, China unveiled a huge and complex health reform plan 
designed to provide all citizens with equal access to basic health care by 2020 [1]. However, the coverage pro-
vided through this program is very small, in terms of both the service benefit package and financial protection 
provided [26]. In many parts of China, outpatient services are under-insured or not covered. Inpatient services, 
if covered, still require patients to bear a number of costs (co-payments, deductibles, or additional fees). For 
instance, the rural cooperative medical scheme only reimburses about 30% of hospitalization expenses [27]. 
In many cases, medical assistance programs for poor people simply help them participate in the rural scheme 
rather than paying more of the treatment costs. As a result, the access that poor people actually have to prima-
ry care has not really improved, and financial protection against high medical costs remains very limited [16]. 
In the present study, the mortality rate was significantly higher among male patients not using medical insur-
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ance than among those using it. This was especially true among patients aged ≥65 years who had a mortality 
rate that was 58.5% higher than for those with medical insurance. Therefore, to effectively reduce the stroke 
burden, the government will need to formulate health insurance policies that are more in-line with the ability 
of low-income people to pay for their medical services.
This study has several limitations. First, the study population was from one township in northern China, which 
is not representative of the overall rural population of China. However, the consistency of the national medical 
insurance policy allows these results to represent the overall situation in rural China. Second, the number of 
stroke cases was limited. However, the observation time was 391 748 person-years, which meets the criterion 
for epidemiological studies in stroke patient populations. Third, early in this study, the low rate of neuroim-
aging-based diagnoses may have affected the determination of stroke types. Fourth, the study population was 
characterized as being low-income and poorly educated, with access to poor medical services. Thus, some pa-
tients with acute attacks may not have been diagnosed in a timely manner, leading to an underestimation of 
the recurrence rate.
CONCLUSIONS
Compared to the 1992-2008 period, the percentages of stroke patients diagnosed using neuroimaging and 
who were hospitalized were significantly higher during the 2009-2018 period. Further, the stroke case fatality 
rate was remarkably higher among patients not using medical insurance than among those who used medical 
insurance; the stroke recurrence rate also showed a downward trend after 2009. Moreover, men without ade-
quate medical insurance benefits, due to their low incomes, demonstrated high mortality rates. These findings 
suggest that the universal medical insurance for urban and rural residents, in China, has played a major role in 
improving the management and prognoses of first-ever stroke patients residing in rural, low-income areas of 
China, especially for patients aged ≥65 years. However, there is a crucial need for the government to restruc-
ture its medical insurance policy to facilitate access to medical care by low-income, rural residents to reduce 
the stroke burden in China, especially for those poverty residents.
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